MDCG guidance
Q&A Rev. 2: Q&A on practical aspects related to the implementation of Regulation (EU) 2023/607 - Extension of the MDR transitional period and removal of the “sell off” periods
MDCG guidance · Other topics · July 2024
Key facts
| Reference | Q&A Rev. 2 |
|---|---|
| Title | Q&A on practical aspects related to the implementation of Regulation (EU) 2023/607 - Extension of the MDR transitional period and removal of the “sell off” periods |
| Topic | Other topics |
| Published | July 2024 |
| Document | health.ec.europa.eu |
At a glance
- Yes Full text searchable in Orca1
- Q&A Rev. 2 (July 2024), Q&A Rev. 1 (July 2023) Revisions on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About MDCG guidance documents
The Medical Device Coordination Group (MDCG), made up of EU member-state experts, endorses guidance on applying the Medical Devices Regulation (EU) 2017/745 and the In Vitro Diagnostic Regulation (EU) 2017/746. Each page here covers one document and all of its revisions.